J 2021

Open-access quantitative MRI data of the spinal cord and reproducibility across participants, sites and manufacturers

COHEN-ADAD, Julien; Eva ALONSO-ORTIZ; Mihael ABRAMOVIC; Carina ARNEITZ; Nicole ATCHESON et. al.

Basic information

Original name

Open-access quantitative MRI data of the spinal cord and reproducibility across participants, sites and manufacturers

Authors

COHEN-ADAD, Julien; Eva ALONSO-ORTIZ; Mihael ABRAMOVIC; Carina ARNEITZ; Nicole ATCHESON; Laura BARLOW; Robert L BARRY; Markus BARTH; Marco BATTISTON; Christian BÜCHEL; Matthew BUDDE; Virginie CALLOT; Anna J E COMBES; Benjamin De LEENER; Maxime DESCOTEAUX; Paulo Loureiro de SOUSA; Marek DOSTÁL (203 Czech Republic, belonging to the institution); Julien DOYON; Adam DVORAK; Falk EIPPERT; Karla R EPPERSON; Kevin S EPPERSON; Patrick FREUND; Jürgen FINSTERBUSCH; Alexandru FOIAS; Michela FRATINI; Issei FUKUNAGA; Claudia A M Gandini WHEELER-KINGSHOTT; Giancarlo GERMANI; Guillaume GILBERT; Federico GIOVE; Charley GROS; Francesco GRUSSU; Akifumi HAGIWARA; Pierre-Gilles HENRY; Tomáš HORÁK (203 Czech Republic, belonging to the institution); Masaaki HORI; James JOERS; Kouhei KAMIYA; Haleh KARBASFOROUSHAN; Miloš KEŘKOVSKÝ (203 Czech Republic, belonging to the institution); Ali KHATIBI; Joo-Won KIM; Nawal KINANY; Hagen H KITZLER; Shannon KOLIND; Yazhuo KONG; Petr KUDLIČKA (203 Czech Republic, belonging to the institution); Paul KUNTKE; Nyoman D KURNIAWAN; Slawomir KUSMIA; René LABOUNEK; Maria Marcella LAGANÀ; Cornelia LAULE; Christine S LAW; Christophe LENGLET; Tobias LEUTRITZ; Yaou LIU; Sara LLUFRIU; Sean MACKEY; Eloy MARTINEZ-HERAS; Loan MATTERA; Igor NESTRASIL; Kristin P O GRADY; Nico PAPINUTTO; Daniel PAPP; Deborah PARETO; Todd B PARRISH; Anna PICHIECCHIO; Ferran PRADOS; Àlex ROVIRA; Marc J RUITENBERG; Rebecca S SAMSON; Giovanni SAVINI; Maryam SEIF; Alan C SEIFERT; Alex K SMITH; Seth A. SMITH; Zachary A. SMITH; Elisabeth SOLANA; Y. SUZUKI; George TACKLEY; Alexandra TINNERMANN; Jan VALOŠEK; Dimitri Van De VILLE; Marios C. YIANNAKAS; Kenneth A. II. WEBER; Nikolaus WEISKOPF; Richard G. WISE; Patrik O. WYSS and Junqian XU

Edition

Scientific Data, Berlin, Nature Research, 2021, 2052-4463

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30210 Clinical neurology

Country of publisher

Germany

Confidentiality degree

is not subject to a state or trade secret

References:

Impact factor

Impact factor: 8.501

RIV identification code

RIV/00216224:14110/21:00120180

Organization unit

Faculty of Medicine

UT WoS

000686651700001

EID Scopus

2-s2.0-85112695767

Keywords in English

spinal cord; reproducibility; MRI

Tags

International impact, Reviewed
Changed: 9/10/2024 13:29, Ing. Jana Kuchtová

Abstract

V originále

In a companion paper by Cohen-Adad et al. we introduce the spine generic quantitative MRI protocol that provides valuable metrics for assessing spinal cord macrostructural and microstructural integrity. This protocol was used to acquire a single subject dataset across 19 centers and a multi-subject dataset across 42 centers (for a total of 260 participants), spanning the three main MRI manufacturers: GE, Philips and Siemens. Both datasets are publicly available via git-annex. Data were analysed using the Spinal Cord Toolbox to produce normative values as well as inter/intra-site and inter/intra-manufacturer statistics. Reproducibility for the spine generic protocol was high across sites and manufacturers, with an average inter-site coefficient of variation of less than 5% for all the metrics. Full documentation and results can be found at https://spine-generic.rtfd.io/. The datasets and analysis pipeline will help pave the way towards accessible and reproducible quantitative MRI in the spinal cord.

Links

NV18-04-00159, research and development project
Name: Využití pokročilých magneticko-rezonančních technik k odhalení patofyziologie a zlepšení diagnostiky a praktického managementu degenerativní komprese krční míchy
Investor: Ministry of Health of the CR
681094, interní kód MU
Name: NISCI - Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European randomized double blinded placebo controlled phase II clinical proof of concept trial (Acronym: NISCI)
Investor: European Union, Health, demographic change and wellbeing (Societal Challenges)
90129, large research infrastructures
Name: Czech-BioImaging II